| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/24/2005 | WO2005017192A2 Screening for gestational disorders |
| 02/24/2005 | WO2005017189A2 Neural cell assay |
| 02/24/2005 | WO2005017187A2 Methods for screening and identifying compounds |
| 02/24/2005 | WO2005017184A2 Method for the enumeration of micronucleated erythrocyte populations while distinguishing platelets and/or platelet-associated aggregates |
| 02/24/2005 | WO2005017180A2 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels |
| 02/24/2005 | WO2005017179A2 Antibodies that recognize and bind phosphorylated human androgen receptor and methods of using same |
| 02/24/2005 | WO2005017177A2 Modulators of nod1 signaling |
| 02/24/2005 | WO2005017168A1 Expression of human milk proteins in transgenic plants |
| 02/24/2005 | WO2005017163A2 Phenotypic knockout of cell-surface proteins |
| 02/24/2005 | WO2005017146A1 Interaction inhibitors, method of detecting interaction inhibitor and kit for detecting interaction inhibitor |
| 02/24/2005 | WO2005017136A1 Methods and compositions for determination of glycated proteins |
| 02/24/2005 | WO2005017133A1 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/24/2005 | WO2005017129A1 Phosphoramide and uses thereof |
| 02/24/2005 | WO2005017125A2 Method for isolation and replication of infectious human hepatitis-c virus |
| 02/24/2005 | WO2005017123A2 Mptens as modifiers of the pten pathway and methods of use |
| 02/24/2005 | WO2005017122A2 Biocompatibile linkers for surface plasmon resonance biosensors |
| 02/24/2005 | WO2005017121A2 Mbcats as modifiers of the beta-catenin pathway and methods of use |
| 02/24/2005 | WO2005017119A2 Ups as modifiers of the beta catenin pathway and methods of use |
| 02/24/2005 | WO2005017118A2 Sulfs as modifiers of the beta catenin pathway and methods of use |
| 02/24/2005 | WO2005017117A2 Multipotent amniotic fetal stem cells (mafsc) and banking of same |
| 02/24/2005 | WO2005017112A2 Methods of inhibiting cancer growth by binding to nuclear receptors |
| 02/24/2005 | WO2005017110A2 Engineered proteases for affinity purification and processing of fusion proteins |
| 02/24/2005 | WO2005017109A2 Nucleic acids and polypeptides required for cell survival in the absence of rb |
| 02/24/2005 | WO2005017107A2 Specific binding agents to hepatocyte growth factor |
| 02/24/2005 | WO2005017106A2 Libraries of optimized cytochrome p450 enzymes and the optimized p450 enzymes |
| 02/24/2005 | WO2005017094A2 N-acetyl compositions as adjunct therapy for treatment and prevention of cysteine/glutathione deficiency |
| 02/24/2005 | WO2005017093A2 Polypeptides of streptococcus pyogenes |
| 02/24/2005 | WO2005016971A1 Organic material-immobiling structure and method for production of the same, and peptide and dna therefor |
| 02/24/2005 | WO2005016957A1 REAGENT FOR AMPLIFYING AMYLOID FIBROSIS OF AMYLOID β-PROTEIN |
| 02/24/2005 | WO2005016956A1 Method for detecting transient ligand interactions |
| 02/24/2005 | WO2005016954A2 Immunologic activity measure(s) for t “helper” on-associated conditions |
| 02/24/2005 | WO2005016874A2 Crown ether derivatives |
| 02/24/2005 | WO2005016527A2 Non-pressure based fluid transfer in assay detection systems and related methods |
| 02/24/2005 | WO2005016515A2 Colorable microspheres for dna and protein microarray |
| 02/24/2005 | WO2005016398A2 Molecular probe and material for the detection of an analyte, and use thereof |
| 02/24/2005 | WO2005016382A1 Antibodies to c-met |
| 02/24/2005 | WO2005016374A1 Regulation of urokinase receptor expression by phosphoglycerate kinase |
| 02/24/2005 | WO2005016287A2 Prkwnks as modifiers of the rac pathway and methods of use |
| 02/24/2005 | WO2005016282A2 Prkcs as modifiers of the beta catenin pathway and methods of use |
| 02/24/2005 | WO2005016281A2 Diagnosis and treatment of malignant neoplasms |
| 02/24/2005 | WO2005016279A2 Melks as modifiers of the rac pathway and methods of use |
| 02/24/2005 | WO2005016248A2 A novel antiproliferative factor and methods of use |
| 02/24/2005 | WO2005016231A2 Agents and methods for treatment of disease by oligosaccharide targeting agents |
| 02/24/2005 | WO2005016230A2 Evaluating protein signatures |
| 02/24/2005 | WO2005016196A1 Compositions and methods for destabilizing lysosomes to increase oncogenic or aberrant protein degradation |
| 02/24/2005 | WO2005016132A2 Diagnostics for sars virus |
| 02/24/2005 | WO2005016127A2 Prion-specific peptide reagents |
| 02/24/2005 | WO2005016126A2 Multifactorial assay for cancer detection |
| 02/24/2005 | WO2005016122A2 Npas3 mutant mice and uses for screening and testing therapies for schizophrenia and related neurological disorders |
| 02/24/2005 | WO2005016115A2 Biosensors utilizing dendrimer-immobilized ligands and their use thereof |
| 02/24/2005 | WO2005016045A1 Indicator device |
| 02/24/2005 | WO2005008252A3 Methods and compositions for assaying homocysteine |
| 02/24/2005 | WO2005003763A3 Diagnostics and therapeutics for diseases associated with mas related g-protein coupled receptor 3 (mrgx3) |
| 02/24/2005 | WO2005001426A3 Micro scale flow through sorbent plate collection device |
| 02/24/2005 | WO2004108749A3 Binding peptides: methods for their generation and use |
| 02/24/2005 | WO2004102199A3 Method for selecting and producing vaccine components and vaccines based thereon |
| 02/24/2005 | WO2004101762A3 Detection and treatment of cancers of the colon |
| 02/24/2005 | WO2004099106A3 Facilitated forward chemical genetics using tagged triazine library |
| 02/24/2005 | WO2004092729A3 Method for screening process conditions of a chemical coupling reaction and kits therefor |
| 02/24/2005 | WO2004090145A3 Compounds and methods to enhance raav transduction |
| 02/24/2005 | WO2004087195A3 Therapeutic use of modulators of notch and/or kruppel-like factors |
| 02/24/2005 | WO2004084818A3 Measurement of estrogen activity in plants and a composition therefrom |
| 02/24/2005 | WO2004083436A3 Novel bt toxin receptors and methods of use |
| 02/24/2005 | WO2004081576A3 Association of polymorphic kinase anchor proteins with cardiac phenotypes and related methods |
| 02/24/2005 | WO2004078232A3 Collection device adapted to accept cartridge for point of care system |
| 02/24/2005 | WO2004077062B1 Method for selecting a candidate drug compound |
| 02/24/2005 | WO2004071641A3 Self-assembling arrays and uses thereof |
| 02/24/2005 | WO2004071162A3 Apparatus and method for collecting soil solution samples |
| 02/24/2005 | WO2004070051A3 Chemical proteomics |
| 02/24/2005 | WO2004069258A3 Use of the sgk gene family for diagnosis and therapy of cataracts and glaucoma |
| 02/24/2005 | WO2004063708A3 Compensated infrared absorption sensor for carbon dioxide and other infrared absorbing gases |
| 02/24/2005 | WO2004056865A3 Method of modulation of interaction between receptor and ligand |
| 02/24/2005 | WO2004055196A3 Method for identifying risk of breast cancer and treatments thereof |
| 02/24/2005 | WO2004042352A3 Substrates of n-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates |
| 02/24/2005 | WO2004040257A3 Nox monitor using differential mobility spectrometry |
| 02/24/2005 | WO2004038045A3 Method for diagnosing diffuse-type gastric cancer |
| 02/24/2005 | WO2004036177A3 Assays to detect or quantify bacterial or viral pathogens and contaminants |
| 02/24/2005 | WO2004036171A3 Disease detection by digital protein truncation assays |
| 02/24/2005 | WO2004031725A3 Ratios of collagen peptides, their uses and products |
| 02/24/2005 | WO2004031409A3 Method for diagnosing chronic myeloid leukemia |
| 02/24/2005 | WO2004024088A3 Design of chemokine analogs for the treatment of human diseases |
| 02/24/2005 | WO2004021871A3 Hcv assay |
| 02/24/2005 | WO2004017816A3 Methods for diagnosing dementia-related neurological disorders |
| 02/24/2005 | WO2004017066A8 A system and a method for observing and predicting physiological state of an animal |
| 02/24/2005 | WO2004011594A8 Novel method for analyzing nucleic acid and use thereof for evaluating the degree of mrna editing of the serotonin 5-ht2c receptor |
| 02/24/2005 | WO2004005530A3 Compositions and methods for treatment and detection of multiple cancers |
| 02/24/2005 | WO2003102206A3 Sgk and nedd used as diagnostic and therapeutic targets |
| 02/24/2005 | WO2003093503A3 Method for bioequivalence determination using expression profiling |
| 02/24/2005 | WO2003091687A8 Method and compound for detecting traces of blood |
| 02/24/2005 | WO2003087314A3 Method for isolating and measuring proliferation of long-term label retaining cells and stem cells |
| 02/24/2005 | WO2003053921A3 Mutant proteinase inhibitors and uses thereof |
| 02/24/2005 | US20050044582 Novel polynucleotides and uses therefor |
| 02/24/2005 | US20050044406 Adaptive behavioral intrusion detection systems and methods |
| 02/24/2005 | US20050044122 System and method for predicting the interaction between proteins based on domain combination |
| 02/24/2005 | US20050043898 Method and system for analyzing coatings undergoing exposure testing |
| 02/24/2005 | US20050043897 Biometric compatibility matching system |
| 02/24/2005 | US20050043896 Physical-chemical property based sequence motifs and methods regarding same |
| 02/24/2005 | US20050043894 Integrated biosensor and simulation system for diagnosis and therapy |
| 02/24/2005 | US20050043893 Method, apparatus and article for data reduction |
| 02/24/2005 | US20050043593 Process for discriminating between biological states based on hidden patterns from biological data |